While the vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are administered, and extensive research is conducted for targeted therapeutics to control the COVID-19 ...
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results